Search Results 1541-1550 of 19487 for Myocardium
Stroke, myocardial infarction, deep venous thrombosis, pulmonary or arterial embolism within 6 months prior to Screening 13. If female, pregnant or ...
... myocardial infarction. History of ventricular dysrhythmias or risk factors for ventricular dysrhythmias such as structural heart disease (e.g., severe left ...
... myocardial infarction within 6 months before first dose, or severe pulmonary hypertension. Has treatment with strong cytochrome P 3A (CYP3A) inducers within ...
... myocardial infarction, or cardiac symptoms consistent with New York Heart Association (NYHA) Class III-IV within 6 months prior to their first dose of study ...
Acute myocardial infarction or angina pectoris ≤ 6 months prior to starting study drug; Serum cardiac troponin (cTn) level ≥ 99% percentile of the upper ...
Recent myocardial infarction or coronary revascularization (less than 3 months). Uncontrolled hypertension. Known succinic semi-aldehyde dehydrogenase ...
Examples include but not limited to acute myocardial infarction, acute stroke, uncompensated congestive heart failure, or decompensated liver disease. NOTE ...
History of myocardial infarction =< 12 months prior to registration, severe/unstable angina, systematic congestive heart failure (CHF) New York Heart ...
History of myocardial infarction ≤6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening ventricular ...
New York Heart Association Class III or IV cardiac disease, or myocardial infarction, severe unstable angina, coronary/peripheral artery bypass graft, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!